Skip to main content
    O

    Onconetix Inc (ONCO)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $2.91
    -0.30 (-9.35%)

    Market Cap: $2.15M

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Onconetix Inc (ONCO) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to Onconetix are Imunon (IMNN), XORTX Therapeutics (XRTX) and Curis (CRIS). By market cap, Onconetix ranks 8th of the 13 companies on this page; CNS Pharmaceuticals (CNSP) is the largest at $4.22M.

    Peer Comparison

    ONCO's revenue growth of -83.9% is below the peer median of 0.0%. Like the median peer, it pays no dividend.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    Onconetix (ONCO)$2.15MN/A1.0x0.0%N/A-83.9%0.00%
    Imunon Inc (IMNN)$4.08MN/AN/A0.0%-131.5%0.0%0.00%
    XORTX Therapeutics Inc (XRTX)$2.00MN/AN/A0.0%N/A0.0%0.00%
    Curis Inc (CRIS)$2.97MN/A1.6x0.0%N/A-66.0%0.00%
    Ernexa Therapeutics Inc. (ERNA)$2.84MN/AN/A0.0%N/A-94.1%0.00%
    HCW Biologics Inc (HCWB)$1.73MN/A0.2x-83.1%-51.6%1970.0%0.00%
    Bioatla Inc (BCAB)$2.89MN/AN/A0.0%N/A31.6%0.00%
    Calidi Biotherapeutics Inc. (CLDI)$2.29MN/AN/A0.0%N/A0.0%0.00%
    Genprex Inc (GNPX)$1.71MN/AN/A0.0%N/A0.0%0.00%
    Kairos Pharma, Ltd. (KAPA)$1.54MN/AN/A0.0%N/A0.0%0.00%
    Scinai Immunotherapeutics Ltd (SCNI)$1.05MN/AN/A-80.1%N/A572.0%0.00%
    CNS Pharmaceuticals Inc (CNSP)$4.22MN/AN/A0.0%N/A0.0%0.00%
    Neurosense Therapeutics Ltd (NRSN)$3.21MN/AN/A0.0%N/A0.0%0.00%
    Peer median$2.56MN/A0.9x0.0%-91.6%0.0%0.00%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to Onconetix, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.

    CompanyAboutPeers
    Imunon Inc (IMNN)
    Imunon Inc. is a clinical-stage biotechnology company at the forefront of developing innovative immune-mediated therapies targeting cancer and infectious...
    IMNN competitors
    XORTX Therapeutics Inc (XRTX)
    XORTX Therapeutics Inc., a biopharmaceutical company, is dedicated to the development and commercialization of therapies to treat progressive kidney disease...
    XRTX competitors
    Curis Inc (CRIS)
    Curis, Inc., a biotechnology company, is dedicated to the discovery and development of drug candidates for the treatment of human cancers in the United States.
    CRIS competitors
    Ernexa Therapeutics Inc. (ERNA)
    Brooklyn ImmunoTherapeutics, Inc., a clinical-stage biopharmaceutical company, is dedicated to developing therapies to treat cancer patients.
    ERNA competitors
    HCW Biologics Inc (HCWB)
    HCW Biologics Inc is a forward-thinking biotechnology company focused on pioneering immunotherapies and vaccine technologies to tackle pressing health issues...
    HCWB competitors
    Bioatla Inc (BCAB)
    BioAtla, Inc., a biopharmaceutical company, develops specific and selective antibody-based therapies for the treatment of various cancers.
    BCAB competitors
    Calidi Biotherapeutics Inc. (CLDI)
    Calidi Biotherapeutics, Inc., a clinical stage immuno-oncology company, engages in developing immunotherapies for the treatment of cancer.
    CLDI competitors
    Genprex Inc (GNPX)
    Genprex, Inc., a clinical-stage gene therapy company, focuses on developing therapies for patients with cancer and diabetes.
    GNPX competitors
    Kairos Pharma, Ltd. (KAPA)
    Kairos Pharma, Ltd. is a clinical-stage biopharmaceutical company that develops therapeutics for cancer patients.
    KAPA competitors
    Scinai Immunotherapeutics Ltd (SCNI)
    Scinai Immunotherapeutics Ltd is an innovative biotechnology company focused on developing cutting-edge immunotherapy solutions for cancer and autoimmune...
    SCNI competitors
    CNS Pharmaceuticals Inc (CNSP)
    CNS Pharmaceuticals, Inc., a clinical pharmaceutical company, is dedicated to the development of cancer drug candidates for the treatment of brain and central...
    CNSP competitors
    Neurosense Therapeutics Ltd (NRSN)
    Neurosense Therapeutics Ltd (NRSN) is a clinical-stage biotechnology firm dedicated to innovating treatments for neurodegenerative diseases...

    Frequently Asked Questions About ONCO

    Who are Onconetix's main competitors?

    The companies most similar to Onconetix include Imunon (IMNN), XORTX Therapeutics (XRTX), Curis (CRIS), Ernexa Therapeutics (ERNA) and HCW Biologics (HCWB), listed from the closest match.

    Who is Onconetix's biggest competitor?

    CNS Pharmaceuticals (CNSP) is the largest of the similar companies at $4.22M; Imunon (IMNN) is the closest match by business profile, size, sector and industry.

    How does ONCO stock compare with its competitors?

    ONCO's P/S is 1.0x against a peer median of 0.9x; its net margin is 0.0% against a peer median of 0.0%.

    Which of Onconetix's competitors pays a higher dividend?

    Onconetix pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.

    Is Onconetix bigger than its competitors?

    No. Onconetix is 8th by market cap among the 13 companies on this page; the largest is CNS Pharmaceuticals (CNSP) at $4.22M.